UA113103C2 - Спосіб непрямої оцінки патологічної концентрації токсичних металів та металоїдів в тканинах серця та магістральних судинах у дітей - Google Patents
Спосіб непрямої оцінки патологічної концентрації токсичних металів та металоїдів в тканинах серця та магістральних судинах у дітей Download PDFInfo
- Publication number
- UA113103C2 UA113103C2 UAA201503417A UAA201503417A UA113103C2 UA 113103 C2 UA113103 C2 UA 113103C2 UA A201503417 A UAA201503417 A UA A201503417A UA A201503417 A UAA201503417 A UA A201503417A UA 113103 C2 UA113103 C2 UA 113103C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tissues
- concentration
- hair
- heart
- children
- Prior art date
Links
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 22
- 239000002184 metal Substances 0.000 title claims abstract description 22
- 150000002739 metals Chemical class 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 22
- 231100000331 toxic Toxicity 0.000 title claims abstract description 17
- 230000002588 toxic effect Effects 0.000 title claims abstract description 17
- 230000001575 pathological effect Effects 0.000 title claims abstract description 16
- 210000002216 heart Anatomy 0.000 title claims abstract description 12
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 26
- 210000004209 hair Anatomy 0.000 claims abstract description 25
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims abstract description 13
- 210000000748 cardiovascular system Anatomy 0.000 claims abstract description 13
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 13
- 229910052752 metalloid Inorganic materials 0.000 claims abstract description 13
- 150000002738 metalloids Chemical class 0.000 claims abstract description 13
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 13
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052712 strontium Inorganic materials 0.000 claims abstract description 10
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 10
- 239000010936 titanium Substances 0.000 claims abstract description 10
- 231100000614 poison Toxicity 0.000 claims abstract description 9
- 239000003440 toxic substance Substances 0.000 claims abstract description 9
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 210000002700 urine Anatomy 0.000 claims abstract description 8
- 229910052785 arsenic Inorganic materials 0.000 claims abstract description 7
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052788 barium Inorganic materials 0.000 claims abstract description 7
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000001519 tissue Anatomy 0.000 description 21
- 229910052729 chemical element Inorganic materials 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000003754 fetus Anatomy 0.000 description 8
- 239000011575 calcium Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 208000028831 congenital heart disease Diseases 0.000 description 6
- 210000004379 membrane Anatomy 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 238000010219 correlation analysis Methods 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 208000002330 Congenital Heart Defects Diseases 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000000709 aorta Anatomy 0.000 description 4
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 4
- 238000001574 biopsy Methods 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229910052750 molybdenum Inorganic materials 0.000 description 4
- 210000000282 nail Anatomy 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 208000006179 Aortic Coarctation Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010009807 Coarctation of the aorta Diseases 0.000 description 3
- 238000001636 atomic emission spectroscopy Methods 0.000 description 3
- 238000000889 atomisation Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000009616 inductively coupled plasma Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000003169 placental effect Effects 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 210000001147 pulmonary artery Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 210000003017 ductus arteriosus Anatomy 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000036244 malformation Effects 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000001006 meconium Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 230000036266 weeks of gestation Effects 0.000 description 2
- 206010004552 Bicuspid aortic valve Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241000953561 Toia Species 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000021654 bicuspid aortic valve disease Diseases 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000006860 carbon metabolism Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 231100000313 clinical toxicology Toxicity 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 208000018548 hypothalamic dysfunction Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002782 sympathoadrenal effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201503417A UA113103C2 (xx) | 2015-04-10 | 2015-04-10 | Спосіб непрямої оцінки патологічної концентрації токсичних металів та металоїдів в тканинах серця та магістральних судинах у дітей |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201503417A UA113103C2 (xx) | 2015-04-10 | 2015-04-10 | Спосіб непрямої оцінки патологічної концентрації токсичних металів та металоїдів в тканинах серця та магістральних судинах у дітей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA113103C2 true UA113103C2 (xx) | 2016-12-12 |
Family
ID=58044279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201503417A UA113103C2 (xx) | 2015-04-10 | 2015-04-10 | Спосіб непрямої оцінки патологічної концентрації токсичних металів та металоїдів в тканинах серця та магістральних судинах у дітей |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA113103C2 (xx) |
-
2015
- 2015-04-10 UA UAA201503417A patent/UA113103C2/uk unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Herrera et al. | Clinical characteristics of chronic kidney disease of nontraditional causes in Salvadoran farming communities | |
| Umarova et al. | Early diagnostics of echinococcosis in children | |
| Zhumalina et al. | Development of scientifically justified proposals on the prevention and treatment of environmentally determined constitutional growth delay in children in the West Kazakhstan region | |
| UA113103C2 (xx) | Спосіб непрямої оцінки патологічної концентрації токсичних металів та металоїдів в тканинах серця та магістральних судинах у дітей | |
| Erickson | An approach to the examination of the fetal congenitally malformed heart at autopsy | |
| RU2558075C2 (ru) | Способ прогнозирования риска снижения уровня здоровья ребенка в возрасте 12-16 лет | |
| RU2535044C1 (ru) | Способ определения биологического возраста трупа при повторной кровопотере | |
| RU2538219C2 (ru) | Способ определения резистентности тромбоцитов к ацетилсалициловой кислоте | |
| Qiao et al. | Tiny cystine stones in the gallbladder of a patient with cholecystolithiasis complicating acute cholecystitis: a case report | |
| RU2737523C1 (ru) | Способ диагностики предраковых заболеваний слизистой оболочки полоста рта | |
| RU111763U1 (ru) | Устройство для забора слюны | |
| RU2437103C2 (ru) | Способ определения нарушения обмена холестерина в организме | |
| RU2194988C2 (ru) | Способ прогнозирования течения идиопатического сколиоза | |
| RU2414706C1 (ru) | Способ раннего прогнозирования септических осложнений у новорожденных с респираторной патологией | |
| RU2561836C1 (ru) | Способ определения степени нарушения структуры печени и выраженности портальной гипертензии у детей | |
| Tang et al. | Predictive Model for Severe Coronary Artery Calcification in ESKD Patients | |
| Suvila et al. | Early onset hypertension is robustly associated with hypertensive organ damage | |
| RU2188426C2 (ru) | Способ дифференциальной диагностики дефекта осанки и идиопатического сколиоза | |
| RU2423706C1 (ru) | Способ диагностики острого холецистита | |
| SU1617373A1 (ru) | Способ определени физического состо ни организма | |
| McKenzie | Diagnosis of cancer of lung and stomach | |
| RU2479258C1 (ru) | Способ диагностики инфекционно-воспалительного процесса органов дыхания у детей | |
| Mirzarakhimova et al. | CONGENITAL ANOMALIES IN CHILDREN PREVALENCE AND RISK FACTORS | |
| ASLAM et al. | CLINICAL SPECTRUM OF CHRONIC KIDNEY DISEASE: A STUDY OF 50 PATIENTS AT LUMHS. | |
| RU2392621C1 (ru) | Способ диагностики ацидоза |